UNSPSC 51372105: Ethylmorphine

This classification denotes an opioid receptor agonist with the molecular structure C19H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, RWO67D87EU chemically known as (5.alpha.,6.alpha.)-7,8-didehydro-4,5-epoxy-3-ethoxy-17-methylmorphinan-6-ol but generally known as ethylmorphine, which bears US NIH Compound Identifier 5359271. European Medicines Agency schedules Ethylmorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13765MIG.

As of Q4 2014, ETHYLMORPHINE remains the US FDA Preferred Term for this commodity. Ethylmorphine bears US NLM identifiers UMLS ID C0015109 and NCI Concept Code C83704. SMILES: O1C2C34C(C(N(CC3)C)CC3C4C1C(OCC)CC3)C=CC2O.

UNSPSC 51372105 Ethylmorphine is a Commodity code that in recent state and local procurement activity covers pharmaceutical supplies related to emergency response and drug intervention — specifically naloxone (a opioid antagonist) and drug deactivation systems procured by health and safety agencies for community health initiatives. State and local governments use this code family for acquisition of controlled and prescription medications, including emergency life-saving drugs and associated containment or disposal products. Issuing bodies include county health departments and community health agencies; the recent activity reflects acquisition by public health and emergency-response functions rather than retail or manufacturing operations.

Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 seeking to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The procurement required electronic bid submission through the county's e-Procurement Portal, with vendors responsible for all shipping and delivery costs, and included a two-year initial term with a one-year renewal option. Bidders faced standard compliance requirements including drug-free workplace certification, E-Verify eligibility verification, and specified insurance coverage (workers' compensation, commercial general liability, and professional liability). The contract included a three-month probationary period permitting termination without cause and potential FEMA funding with attendant federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. Recent state and local solicitation activity under this code is sparse; the single recorded opportunity represents acquisition by a single Florida county health agency.